Results 321 to 330 of about 934,412 (371)

Atrial cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala, Monika Przewłocka‐Kosmala   +1 more
wiley   +1 more source

Age‐related penetrance of phospholamban p.Arg14del cardiomyopathy

European Journal of Heart Failure, EarlyView.
Age‐related penetrance of phospholamban (PLN) p.Arg14del cardiomyopathy. ECG, electrocardiogram; ICD, implantable cardioverter‐defibrillator; LVAD, left ventricular assist device; LVEF, left ventricular ejection fraction; MRI, magnetic resonance imaging; PVC, premature ventricular contraction; SCD, sudden cardiac death; VF, ventricular fibrillation; VT,
Tom E. Verstraelen, Freyja H.M. van Lint, Remco de Brouwer, Virginnio M. Proost, Esmee van Drie, Laurens P. Bosman, Lotte Weverink, Karim Taha, Thais Bueren, Aeilko H. Zwinderman, Cathelijne Dickhoff, Toon Oomen, Bas A. Schoonderwoerd, Tjeerd Germans, Arjan C. Houweling, Juan R. Gimeno‐Blanes, Folkert W. Asselbergs, Paul A. van der Zwaag, Anneline S.J.M. te Riele, Rudolf A. de Boer, Maarten P. van den Berg, J. Peter van Tintelen, Arthur A.M. Wilde   +22 more
wiley   +1 more source

Ion channels and atrial fibrillation: mitophagy as a key mediator. [PDF]

Front Physiol
Wu X, Yan X, Ma R, Wu Q, Pan X, Wu Q, Ren J, Huang Y, Gao S, Li Y, Gong L.   +10 more
europepmc   +1 more source

Echocardiography guided management of atrial fibrillation. [PDF]

Intensive Care Med
Balik M, Vignon P, Chew MS, Tavazzi G, Mayo P, Doufle G, Aron J, Hastings J, Cholley B, Jiroutkova K, Slama M, Herpain A, McLean A.   +12 more
europepmc   +1 more source

Prognostic value of NT‐proBNP in patients with primary mitral regurgitation undergoing transcatheter edge‐to‐edge repair

European Journal of Heart Failure, EarlyView.
In the PRIME‐MR study, patients with higher N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) tertiles more frequently reached death or heart failure hospitalization (HFH) within 3 years. Log‐transformed NT‐proBNP levels independently predicted the primary endpoint (adjusted hazard ratio 1.17, 95% confidence interval 1.07–1.28; p < 0.001).
Philipp von Stein, Jessica Weimann, Roman Pfister, Sebastian Ludwig, Benedikt Koell, Erwan Donal, Dhairya Patel, Lukas Stolz, Tetsu Tanaka, Andrea Scotti, Teresa Trenkwalder, Felix Rudolph, Daryoush Samim, Cristina Giannini, Julien Dreyfus, Jean‐Michel Paradis, Marianna Adamo, Nicole Karam, Yohann Bohbot, Anne Bernard, Bruno Melica, Angelo Quagliana, Yoan Lavie Badie, Mirjam Kessler, Omar Chehab, Simon Redwood, Edith Lubos, Lars Sondergaard, Marco Metra, Chiara Primerano, Fabien Praz, Muhammed Gerçek, Erion Xhepa, Georg Nickenig, Azeem Latib, Niklas Schofer, Raj Makkar, Juan F. Granada, Thomas Modine, Jörg Hausleiter, Augustin Coisne, Daniel Kalbacher, Christos Iliadis, on behalf of the PRIME‐MR Investigators, Paul Achouh, David Attias, Stephan Baldus, Alain Berrebi, Guillaume Bonnet, Laura Granada, Frederic Bouisset, Corentin Bourg, Thierry Bourguignon, Diogo Ferreira, Stéphane Lafitte, Thibault Lhermusier, Guillaume L'official, Mohammed Nejjari, Edoardo Pancaldi, Lydia X. Plewe, Tobias Rheude, Natacha Rousse, Volker Rudolph, Dan Rusinaru, Christophe Saint‐Etienne, Francisco Sampaio, Jury Schewel, Arnaud Sudre, Christophe Tribouilloy, Marcel Weber, Stephan Windecker   +70 more
wiley   +1 more source

Atrial fibrillation, traumatic fall, and what happens after: it takes a village. [PDF]

Trauma Surg Acute Care Open
Metkus T.
europepmc   +1 more source

Computational modelling of myocardial metabolism in patients with advanced heart failure

European Journal of Heart Failure, EarlyView.
LV, left ventricular; LVAD, left ventricular assist device; LVEF, left ventricular ejection fraction. Abstract Aims Perturbations of myocardial metabolism and energy depletion are well‐established hallmarks of heart failure (HF), yet methods for their systematic assessment remain limited in humans.
Niklas Beyhoff, Vera M. Braun, Marieluise Kirchner, Lucy E.M. Finnigan, Christoph Knosalla, István Baczkó, Evgenij Potapov, Ulrich Kintscher, Tilman Grune, Titus Kuehne, Hermann‐Georg Holzhütter, Philipp Mertins, Damian J. Tyler, Hendrik Milting, Betty Raman, Oliver J. Rider, Stefan Neubauer, Nikolaus Berndt   +17 more
wiley   +1 more source

Lipoprotein(a) and Atrial Fibrillation: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Maj B, Pruc M, Czubak P, Romanska I, Momot K, Klos M, Krauz K, Mielnik A, Siudak Z, Kotfis K, Szarpak L.   +10 more
europepmc   +1 more source

Medication adherence in patients with acutely decompensated heart failure: A cross‐sectional study in the emergency department (ADHF‐ED)

European Journal of Heart Failure, EarlyView.
The ADHF‐ED trial. ADHF, acutely decompensated heart failure; CHF, chronic heart failure; ED, emergency department; EF, ejection fraction; MRA, mineralocorticoid receptor antagonist; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide. Created with the support of AI (ChatGPT).
Michael Kunz, Juel Maalouli Schaar, Katharina R. Welker, Lucas Lauder, Felix Götzinger, Ingrid Kindermann, Martin Schulz, Michael Böhm, Markus R. Meyer, Felix Mahfoud   +9 more
wiley   +1 more source

Can SGLT2 Inhibitors Prevent Atrial Fibrillation in HFpEF? [PDF]

Balkan Med J
Özlek B.
europepmc   +1 more source